{"id":"https://openalex.org/W2018474381","doi":"https://doi.org/10.2165/00003495-200868110-00003","title":"Depressive Symptoms in Epilepsy","display_name":"Depressive Symptoms in Epilepsy","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2018474381","doi":"https://doi.org/10.2165/00003495-200868110-00003","mag":"2018474381","pmid":"https://pubmed.ncbi.nlm.nih.gov/18627207"},"language":"en","primary_location":{"id":"doi:10.2165/00003495-200868110-00003","doi":"https://doi.org/10.2165/00003495-200868110-00003","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00003495-200868110-00003","pdf_url":null,"source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105285968","display_name":"J. Mitchell Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"J Mitchell Miller","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA. jmm43100@gsk.com","Neurosciences Medicines Development Centre, GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA. jmm43100@gsk.com","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028557494","display_name":"Robert P. Kustra","orcid":"https://orcid.org/0000-0003-4491-9732","observed_orcids":["https://orcid.org/0000-0003-4491-9732"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Robert P Kustra","raw_affiliation_strings":["Neurosciences Medicines Development Centre, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, 27709, USA","Neurosciences Medicines Development Centre, GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, 27709, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109919275","display_name":"Alain Vuong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Alain Vuong","raw_affiliation_strings":["Neurosciences Medicines Development Centre, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, 27709, USA","Neurosciences Medicines Development Centre, GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, 27709, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072719649","display_name":"Anne E. Hammer","orcid":"https://orcid.org/0000-0003-0217-3848","observed_orcids":["https://orcid.org/0000-0003-0217-3848"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Anne E Hammer","raw_affiliation_strings":["Neurosciences Medicines Development Centre, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, 27709, USA","Neurosciences Medicines Development Centre, GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, 27709, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060064352","display_name":"John A. Messenheimer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"John A Messenheimer","raw_affiliation_strings":["Neurosciences Medicines Development Centre, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, 27709, USA","Neurosciences Medicines Development Centre, GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, 27709, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"Neurosciences Medicines Development Centre, GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5105285968"],"corresponding_institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4210114143"],"apc_list":{"value":5990,"currency":"USD","value_usd":5990},"apc_paid":null,"fwci":0.8106,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.58992248,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"68","issue":"11","first_page":"1493","last_page":"1509"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/depressive-symptoms","display_name":"depressive symptoms","score":0.7699999809265137},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9079999923706055},{"id":"https://openalex.org/keywords/dysthymia","display_name":"dysthymia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.8830000162124634},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9580000042915344},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.8939999938011169},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.6869999766349792},{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.8309999704360962},{"id":"https://openalex.org/keywords/tiagabine","display_name":"tiagabine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9929999709129333},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":0.968999981880188},{"id":"https://openalex.org/keywords/levetiracetam","display_name":"levetiracetam","score":1.0},{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7668615579605103},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.7552721500396729},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.613629162311554},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4693715572357178},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.33083826303482056},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.15213963389396667}],"mesh":[{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2165/00003495-200868110-00003","doi":"https://doi.org/10.2165/00003495-200868110-00003","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00003495-200868110-00003","pdf_url":null,"source":{"id":"https://openalex.org/S4436492","display_name":"Drugs","issn_l":"0012-6667","issn":["0012-6667","1179-1950"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"journal-article"},{"id":"pmid:18627207","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18627207","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":92,"referenced_works":["https://openalex.org/W9413724","https://openalex.org/W47265956","https://openalex.org/W612266680","https://openalex.org/W650514631","https://openalex.org/W1479790262","https://openalex.org/W1573899044","https://openalex.org/W1579260171","https://openalex.org/W1969401904","https://openalex.org/W1969648109","https://openalex.org/W1971836248","https://openalex.org/W1972686884","https://openalex.org/W1979806259","https://openalex.org/W1981631683","https://openalex.org/W1985964054","https://openalex.org/W1986550991","https://openalex.org/W1990816640","https://openalex.org/W1991762756","https://openalex.org/W1993004124","https://openalex.org/W2004822154","https://openalex.org/W2005383924","https://openalex.org/W2005926974","https://openalex.org/W2006255780","https://openalex.org/W2011366794","https://openalex.org/W2011456118","https://openalex.org/W2013207045","https://openalex.org/W2013336473","https://openalex.org/W2018981935","https://openalex.org/W2021078847","https://openalex.org/W2021422660","https://openalex.org/W2023732836","https://openalex.org/W2024345321","https://openalex.org/W2025495248","https://openalex.org/W2027512306","https://openalex.org/W2029092021","https://openalex.org/W2034535130","https://openalex.org/W2034562662","https://openalex.org/W2035606229","https://openalex.org/W2035671346","https://openalex.org/W2035998652","https://openalex.org/W2038903617","https://openalex.org/W2038944302","https://openalex.org/W2039833971","https://openalex.org/W2042261138","https://openalex.org/W2044452957","https://openalex.org/W2047830407","https://openalex.org/W2053014390","https://openalex.org/W2054204472","https://openalex.org/W2058801099","https://openalex.org/W2059560616","https://openalex.org/W2064171519","https://openalex.org/W2064220942","https://openalex.org/W2064348389","https://openalex.org/W2064611362","https://openalex.org/W2065189091","https://openalex.org/W2066154390","https://openalex.org/W2069961421","https://openalex.org/W2073293459","https://openalex.org/W2075170973","https://openalex.org/W2075948811","https://openalex.org/W2077142362","https://openalex.org/W2077805222","https://openalex.org/W2080202639","https://openalex.org/W2083524390","https://openalex.org/W2086325144","https://openalex.org/W2088440043","https://openalex.org/W2088476265","https://openalex.org/W2088654931","https://openalex.org/W2090080725","https://openalex.org/W2095558066","https://openalex.org/W2099021878","https://openalex.org/W2101906322","https://openalex.org/W2107001839","https://openalex.org/W2109503569","https://openalex.org/W2111887817","https://openalex.org/W2112778345","https://openalex.org/W2122925178","https://openalex.org/W2124800861","https://openalex.org/W2125675050","https://openalex.org/W2131823335","https://openalex.org/W2136618706","https://openalex.org/W2137110871","https://openalex.org/W2146188436","https://openalex.org/W2147043229","https://openalex.org/W2147513543","https://openalex.org/W2156557035","https://openalex.org/W2169061430","https://openalex.org/W2169694527","https://openalex.org/W2411878304","https://openalex.org/W4239594659","https://openalex.org/W4243591461","https://openalex.org/W4285719527","https://openalex.org/W4300282546"],"related_works":["https://openalex.org/W2005926974","https://openalex.org/W2501701092","https://openalex.org/W11850318","https://openalex.org/W3210764472","https://openalex.org/W2099021878","https://openalex.org/W3199409865","https://openalex.org/W568728","https://openalex.org/W7047024257","https://openalex.org/W2039833971","https://openalex.org/W2077142362"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}